ProShares UltraPro Short QQQ, Philip Morris International, Chevron, NIKE, PepsiCo, Pfizer, and Manulife Financial are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that distribute a portion of their earnings to shareholders, typically as cash payments and often on a regular schedule. Investors may buy them for income, but dividends aren’t guaranteed and can be reduced or stopped. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
Shares of NASDAQ SQQQ traded up $2.72 during mid-day trading on Thursday, hitting $49.07. The company had a trading volume of 71,771,859 shares, compared to its average volume of 56,199,324. ProShares UltraPro Short QQQ has a 1 year low of $31.42 and a 1 year high of $90.71. The stock's 50-day moving average price is $38.31 and its 200-day moving average price is $48.84.
Read Our Latest Research Report on SQQQ
Philip Morris International (PM)
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches.
PM traded down $6.50 during trading on Thursday, reaching $186.23. 6,026,906 shares of the company were exchanged, compared to its average volume of 4,984,667. Philip Morris International has a 12-month low of $146.35 and a 12-month high of $214.35. The company's 50-day moving average is $196.95 and its two-hundred day moving average is $183.61. The company has a market cap of $290.27 billion, a price-to-earnings ratio of 27.17, a P/E/G ratio of 2.61 and a beta of 0.34.
Read Our Latest Research Report on PM
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
Shares of CVX traded up $0.36 during midday trading on Thursday, hitting $206.24. 5,376,172 shares of the company traded hands, compared to its average volume of 10,180,479. Chevron has a one year low of $146.49 and a one year high of $236.48. The firm has a market cap of $405.34 billion, a P/E ratio of 15.08, a PEG ratio of 0.50 and a beta of 0.47. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.34 and a quick ratio of 1.07. The stock has a 50-day moving average of $215.63 and a 200-day moving average of $196.19.
Read Our Latest Research Report on CVX
NIKE (NKE)
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks.
NYSE:NKE traded down $2.08 during mid-day trading on Thursday, hitting $34.23. 19,283,167 shares of the stock traded hands, compared to its average volume of 24,667,500. The business's 50-day moving average price is $36.81 and its 200 day moving average price is $44.59. The company has a market cap of $50.84 billion, a PE ratio of 16.44, a price-to-earnings-growth ratio of 4.11 and a beta of 1.01. NIKE has a 12-month low of $31.97 and a 12-month high of $69.14. The company has a quick ratio of 1.39, a current ratio of 2.07 and a debt-to-equity ratio of 0.39.
Read Our Latest Research Report on NKE
PepsiCo (PEP)
PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
PepsiCo stock traded down $3.05 during midday trading on Thursday, reaching $138.82. 4,668,215 shares of the stock were exchanged, compared to its average volume of 8,278,840. PepsiCo has a 52 week low of $123.47 and a 52 week high of $171.48. The company has a debt-to-equity ratio of 1.90, a quick ratio of 0.76 and a current ratio of 0.94. The firm has a market cap of $189.18 billion, a PE ratio of 17.44, a PEG ratio of 4.23 and a beta of 0.31. The company's fifty day moving average is $133.99 and its 200-day moving average is $145.58.
Read Our Latest Research Report on PEP
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
NYSE:PFE traded down $0.47 during trading hours on Thursday, hitting $27.59. The stock had a trading volume of 23,011,445 shares, compared to its average volume of 39,628,922. The company has a 50 day simple moving average of $28.83 and a two-hundred day simple moving average of $27.02. The firm has a market capitalization of $157.23 billion, a price-to-earnings ratio of 39.39, a P/E/G ratio of 1.87 and a beta of 0.31. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.42 and a quick ratio of 1.10. Pfizer has a one year low of $23.62 and a one year high of $31.44.
Read Our Latest Research Report on PFE
Manulife Financial (MFC)
Manulife Financial Corporation, together with its subsidiaries, provides financial products and services in the United States, Canada, Asia, and internationally. The company operates through Wealth and Asset Management Businesses; Insurance and Annuity Products; and Corporate and Other segments. The Wealth and Asset Management Businesses segment offers investment advice and solutions to retirement, retail, and institutional clients through multiple distribution channels, including agents and brokers affiliated with the company, independent securities brokerage firms and financial advisors pension plan consultants, and banks.
Shares of Manulife Financial stock traded down $0.79 during trading on Thursday, hitting $42.22. The stock had a trading volume of 12,208,685 shares, compared to its average volume of 2,159,850. The firm has a market cap of $69.75 billion, a price-to-earnings ratio of 16.71 and a beta of 0.86. Manulife Financial has a 12 month low of $32.58 and a 12 month high of $46.19. The business's 50-day moving average is $43.86 and its 200 day moving average is $40.41.
Read Our Latest Research Report on MFC
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.
While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.